Re: Question for the board!

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

RVXoldtimer

Rank: President [?]

Points: 3198 [?]

Votes: 23 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Question for the board!

in response to

Question for the board!

narmac

posted on Jan 22, 2019 12:13PM

I can't remember when I heard it but it seems to me that DM once said that a listing would probably come when there is an event substantial enough to drive the new listing. I might be remembering wrong but it seems as though he said that once. There are also costs to being listed that they are saving for now.

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply